黄斑中心凹至黄斑下出血边界的最短距离对新生血管性年龄相关性黄斑变性患者具有重要意义
回顾性病例系列纳入16只接受抗血管内皮生长因子(VEGF)治疗、黄斑下出血(SFH)面积大于1个视盘面积(DA)的新生血管性年龄相关性黄斑变性(NVAMD)眼,分析视力与中心子域厚度变化。基线SFH面积较小(r=-0.630;P=.009)与抗VEGF注射频率较高(r=0.646;P=.007)与良好视力预后相关;在基线SFH较大但视力预后良好的特殊患者中,黄斑中心凹至出血边界最短距离与基线视力(r=-0.503,P=.047)和最终视力(r=-0.575,P=.02)显著相关。
要点
- 基线SFH面积较小与良好视力预后相关(r=-0.630;P=.009)。
- 抗VEGF注射频率较高与良好视力预后相关(r=0.646;P=.007)。
- 在基线SFH较大但视力预后良好的特殊患者中,黄斑中心凹至出血边界最短距离与基线视力(r=-0.503,P=.047)和最终视力(r=-0.575,P=.02)相关。
核心结论
- 对于NVAMD合并厚SFH但黄斑中心凹与未受累视网膜之间距离较短的患者,在接受频繁抗VEGF注射时可能获得良好视力预后。
研究设计与样本
- 回顾性病例系列,纳入接受抗VEGF治疗且SFH面积大于1个DA的患眼16只。
主要发现
- 基线SFH平均(±均值标准误)面积为14.9±2.8 DA,厚度为386.6±46.9 μm。
- 基线平均Snellen视力为20/250,中心子域厚度为591.7±57.0 μm。
- 中位随访时间为47.6个月。
- 基线时及至第48周的所有时间点,超过50%的患者视力≤20/200;第6个月和第12个月时视力≥20/50的患者比例增至30%-40%,并保持稳定至第48个月。
- 在基线SFH较大但视力预后良好的特殊患者中,黄斑中心凹至出血边界最短距离与基线视力(r=-0.503,P=.047)和最终视力(r=-0.575,P=.02)显著相关。
关键数值与推荐
- 基线SFH面积较小与良好视力预后相关(r=-0.630;P=.009)。
- 抗VEGF注射频率较高与良好视力预后相关(r=0.646;P=.007)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify factors influencing visual outcome in patients with neovascular age-related macular degeneration (NVAMD) and subfoveal hemorrhage (SFH) treated with anti-vascular endothelial growth factor (VEGF) agents. DESIGN: Retrospective case series. METHODS: Anti-VEGF-treated eyes with SFH > 1 disc area (DA) were identified (n = 16) and changes in visual acuity (VA) and central subfield thickness (CST) from baseline to last follow-up, along with SFH area, thickness, minimum distance from fovea to SFH border, and time to resolution, were determined. RESULTS: At baseline, mean (± standard error of the mean) size and thickness of SFH were 14.9 ± 2.8 DA and 386.6 ± 46.9 μm, and mean Snellen VA and CST were 20/250 and 591.7 ± 57.0 μm. Median follow-up was 47.6 months. While more than 50% of patients had VA ≤ 20/200 at baseline and all time points through week 48, the percentage of patients with VA ≥ 20/50 increased to 30%-40% at months 6 and 12 and remained stable through month 48. Spearman rank correlation demonstrated 2 independent variables that correlated with good visual outcome, smaller area of SFH at baseline (r = -0.630; P = .009), and high frequency of anti-VEGF injections (r = 0.646; P = .007). In exceptional patients with good visual outcome despite large baseline SFH, shortest distance between the fovea and hemorrhage border significantly correlated with baseline VA (r = -0.503, P = .047) and final VA (r = -0.575, P = .02). CONCLUSIONS: Patients with NVAMD and thick SFH, but short distance between fovea and uninvolved retina, can have good visual outcomes when given frequent anti-VEGF injections.
引用
- Kherani S, Scott AW, Wenick AS, et al. Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular Degeneration. Am J Ophthalmol. 2018. PMID: 29499174. doi:10.1016/j.ajo.2018.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。